Sustiva Alternatives Compared
| Sustiva | Truvada | Biktarvy |
|
|---|
| Sustiva (efavirenz) | Truvada (emtricitabine / tenofovir) | Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for HIV Infection, Nonoccupational Exposure, Occupational Exposure. Sustiva may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pre-Exposure Prophylaxis, Nonoccupational Exposure, Occupational Exposure, HIV Infection. Truvada may also be used for purposes not listed in this medication guide. |
Prescription only
Biktarvy is a combination tablet that contains three antiviral agents which may be used to treat HIV-1 in adults and children weighing more than 25kg (55lb). It is generally well-tolerated and the... View more |
||||||||||||||||||||||||
| More about Sustiva (efavirenz) | More about Truvada (emtricitabine / tenofovir) | More about Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide) | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
|||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Sustiva has an average rating of 5.2 out of 10 from a total of 6 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 33% reported a negative effect. |
Truvada has an average rating of 6.4 out of 10 from a total of 34 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 30% reported a negative effect. |
Biktarvy has an average rating of 7.0 out of 10 from a total of 165 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
Common side effects include:
See also: Sustiva side effects in more detail. |
See also: Truvada side effects in more detail. |
See also: Biktarvy side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Sustiva prices and generic prices |
View all Truvada prices |
View all Biktarvy prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other emtricitabine / tenofovir brands include: AccessPak for HIV PEP Basic |
N/A |
||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
76 hours |
25.7 hours |
180 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 706 drugs are known to interact with Sustiva:
|
A total of 210 drugs are known to interact with Truvada:
|
A total of 381 drugs are known to interact with Biktarvy:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
September 17, 1998 |
August 02, 2004 |
February 07, 2018 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.